Drug
Telaprevir
Telaprevir: highest development phase Post-Market, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Telaprevir NCT01467492 | Post-Market | Hepatitis C |
Latest
No recent events.
Follow Telaprevir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.